Shandong Jincheng Pharmaceutical Group Co., Ltd
300233.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | CN¥918 | CN¥1,025 | CN¥859 | CN¥981 |
| Short-Term Investments | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Receivables | CN¥703 | CN¥795 | CN¥803 | CN¥684 |
| Inventory | CN¥599 | CN¥501 | CN¥579 | CN¥391 |
| Other Curr. Assets | CN¥9 | CN¥49 | CN¥66 | CN¥83 |
| Total Curr. Assets | CN¥2,258 | CN¥2,369 | CN¥2,308 | CN¥2,139 |
| Property Plant & Equip (Net) | CN¥2,310 | CN¥2,468 | CN¥2,469 | CN¥2,093 |
| Goodwill | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Intangibles | CN¥754 | CN¥842 | CN¥805 | CN¥765 |
| Long-Term Investments | CN¥183 | CN¥148 | CN¥158 | CN¥158 |
| Tax Assets | CN¥64 | CN¥70 | CN¥52 | CN¥31 |
| Other NC Assets | CN¥36 | CN¥19 | CN¥34 | CN¥90 |
| Total NC Assets | CN¥3,347 | CN¥3,547 | CN¥3,518 | CN¥3,136 |
| Other Assets | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total Assets | CN¥5,605 | CN¥5,916 | CN¥5,826 | CN¥5,275 |
| Liabilities | – | – | – | – |
| Payables | CN¥553 | CN¥824 | CN¥726 | CN¥515 |
| Short-Term Debt | CN¥55 | CN¥94 | CN¥213 | CN¥378 |
| Tax Payable | CN¥43 | CN¥39 | CN¥55 | CN¥47 |
| Deferred Revenue | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Other Curr. Liab. | CN¥156 | CN¥148 | CN¥168 | CN¥218 |
| Total Curr. Liab. | CN¥1,231 | CN¥1,600 | CN¥1,701 | CN¥1,416 |
| LT Debt | CN¥352 | CN¥347 | CN¥272 | CN¥208 |
| Deferred Rev, NC | CN¥54 | CN¥62 | CN¥0 | CN¥55 |
| Deferred Tax Liab, NC | CN¥129 | CN¥123 | CN¥126 | CN¥93 |
| Other NC Liab. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total NC Liab. | CN¥542 | CN¥535 | CN¥466 | CN¥419 |
| Other Liabilities | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Cap. Leases | CN¥7 | CN¥3 | CN¥2 | CN¥64 |
| Total Liabilities | CN¥1,773 | CN¥2,135 | CN¥2,167 | CN¥1,836 |
| Equity | – | – | – | – |
| Pref Stock | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Common Stock | CN¥384 | CN¥384 | CN¥387 | CN¥387 |
| Retained Earnings | CN¥905 | CN¥838 | CN¥735 | CN¥555 |
| AOCI | CN¥206 | CN¥0 | CN¥29 | CN¥127 |
| Other Equity | CN¥0 | CN¥164 | CN¥0 | CN¥0 |
| Total Equity | CN¥3,767 | CN¥3,714 | CN¥3,607 | CN¥3,394 |
| Supplemental Information | – | – | – | – |
| Minority Interest | CN¥65 | CN¥67 | CN¥52 | CN¥45 |
| Total Liab. & Tot. Equity | CN¥5,605 | CN¥5,916 | CN¥5,826 | CN¥5,275 |
| Net Debt | -CN¥511 | -CN¥584 | -CN¥374 | -CN¥394 |